2-Fluoro-5-(trifluoromethyl)pyridine → (2-Fluoro-3-methyl-6-(2H-1,2,3-triazol-2-yl)phenyl)((2S,3R)-3-methyl-2-(((5-(trifluoromethyl)pyridin-2-yl)amino)methyl)piperidin-1-yl)methanone
Reaction equation
[F:1][C:2]1[C:10]([CH3:11])=[CH:9][CH:8]=[C:7]([N:12]2[N:16]=[CH:15][CH:14]=[N:13]2)[C:3]=1[C:4]([OH:6])=O.[CH3:17][C@@H:18]1[CH2:23][CH2:22][CH2:21][NH:20][C@@H:19]1[CH2:24][N:25]1C(=O)C2C(=CC=CC=2)C1=O.F[C:37]1[CH:42]=[CH:41][C:40]([C:43]([F:46])([F:45])[F:44])=[CH:39][N:38]=1>>[F:1][C:2]1[C:10]([CH3:11])=[CH:9][CH:8]=[C:7]([N:12]2[N:16]=[CH:15][CH:14]=[N:13]2)[C:3]=1[C:4]([N:20]1[CH2:21][CH2:22][CH2:23][C@@H:18]([CH3:17])[C@H:19]1[CH2:24][NH:25][C:37]1[CH:42]=[CH:41][C:40]([C:43]([F:46])([F:45])[F:44])=[CH:39][N:38]=1)=[O:6]Participants
4
Reactant 3
Product 1
Procedure
The title compound was prepared following the same general protocol as described in Example A1, using 2-fluoro-3-methyl-6-(2H-1,2,3-triazol-2-yl)benzoic acid, 2-(((2S,3R)-3-methylpiperidin-2-yl)methyl)isoindoline-1,3-dione and 2-fluoro-5-(trifluoromethyl)pyridine. ESI-MS (m/z): 477 [M+1]+. 1H NMR (300 MHz, DMSO-d6) δ 8.45-6.45 (m, 8H), 4.90-2.70 (m, 5H), 2.35-0.65 (m, 11H)
Sources & evidence
- ORD record
- ord-fdfcc71dcae34e62bc7510edefc04aa8
- Source dataset
- uspto-grants-2016_09
- Patent number
- US09440982B2
Reaction notes
Loading…